Share price information for Otsuka Holdings Co.,Ltd., including after-hours PTS trading, along with a summary of its 2026 interim results and upcoming earnings schedule, is provided. Movements in the after-hours trading price and key earnings-related points are set out.
The after-hours PTS trading price was ¥11,420–45 as of 22:33, down 0.39% from the previous day, with a trading volume of 100 shares and trading value of ¥1.142 million. Trading is currently taking place in the after-hours market, and no movement relative to the TSE closing price is shown alongside it.
The next earnings announcement is expected in late October 2026. According to the earnings summary, revenue for the 2026 interim period rose 12.8% year on year to ¥1,332.4 billion, business profit increased 17.3% to ¥280.6 billion, and interim profit attributable to owners of the parent rose 24.3% to ¥215.6 billion, with profit growth outpacing revenue growth. The company also indicated an upward revision to its full-year forecast and plans to increase the annual dividend to ¥200.
Points to monitor in future results include the expansion of prescriptions for key pharmaceuticals, the launch of the U.S. infusion business, growth in the NC category, a lower selling, general and administrative expense ratio, development progress and approvals for multiple products, and expansion into new fields through the acquisition of TSND-201. At the same time, risks cited include the impact of generic drugs and healthcare cost-containment measures, delays in research and development, and fluctuations in expenses due to foreign exchange and raw material trends.
This is a summary of key facts based on the article and does not represent a forecast or investment recommendation.